TrialFind
Saved trials
Back to results
Completed
Phase 3
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
NCT02006654
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
US612
Mesa, Arizona, United States
+106 additional locations
View on ClinicalTrials.gov
Official details